Our results demonstrated that a high expression level of TNRC18 was detected in the serum of patients with ≥50% stenosis in at least one major vessel, indicating a higher probability of immuno-inflammatory response involvement in the pathogenesis of CAD. Here, TNRC18 is linked to coronary artery disorder.